ASSESSMENT OF THE RISK ON ENDOMETRIAL CANCER IN HYPERPLASIA, BY MEANS OF MORPHOLOGICAL AND MORPHOMETRICAL FEATURES

被引:59
|
作者
BAAK, JPA
WISSEBREKELMANS, ECM
FLEEGE, JC
VANDERPUTTEN, HWHM
BEZEMER, PD
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT GYNECOL,1081 HV AMSTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP,DEPT THEORY MED,1081 HV AMSTERDAM,NETHERLANDS
关键词
ENDOMETRIUM; HYPERPLASIA; PROGNOSIS;
D O I
10.1016/S0344-0338(11)80244-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The value of two 'cancer risk " assessment rules (one consisting of qualitative microscopical features and one consisting of morphometric characteristics) bas been evaluated in 39 patients with hyperplasia of the endometrium. Of these, in seven (7139 = 18 %) cancer was detected in the follow-up and 32 remained stable or became less abnormal. The results of the qualitative analysis were well in agreement with those published earlier7. In none of the eight patients with simple hyperplasia cancer was detected, in contrast to five of the 11 patients (45 %) with cytologic atypia and glandular complexity. Twenty patients showed cytologic atypicality in the absence of glandular complexity, or no atypicality but glandular complexity; in two (1 0 %) of these patients cancer was detected later in the follow-up. The morphometric rule (consisting of volume percentage of stroma, log-normally transformed standard deviation of the shortest nuclear axis and outer surface density of the glands) results in a multivariate score. Nineteen patients bad a score value above 0.6 and in none of them cancer was found. In contrast, in seven of the 20 patients (35 %) with a score value below 0.6, cancer was detected. Regarding the question which of the techniques is more powerful the specificity is better with the qualitative evaluations; the sensitivity is higher with the morphometric rule. An advantage of the morphometric rule is that only two groups (very low/very high risk) are discerned.
引用
收藏
页码:856 / 859
页数:4
相关论文
共 50 条
  • [1] Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps
    Savelli, L
    De Iaco, P
    Santini, D
    Rosati, F
    Ghi, T
    Pignotti, E
    Bovicelli, L
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (04) : 927 - 931
  • [2] Endometrial hyperplasia as a risk factor of endometrial cancer
    Lisa K. Nees
    Sabine Heublein
    Sahra Steinmacher
    Ingolf Juhasz-Böss
    Sara Brucker
    Clemens B. Tempfer
    Markus Wallwiener
    Archives of Gynecology and Obstetrics, 2022, 306 : 407 - 421
  • [3] Endometrial hyperplasia as a risk factor of endometrial cancer
    Nees, Lisa K.
    Heublein, Sabine
    Steinmacher, Sahra
    Juhasz-Boess, Ingolf
    Brucker, Sara
    Tempfer, Clemens B.
    Wallwiener, Markus
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (02) : 407 - 421
  • [5] Risk Assessment of Endometrial Hyperplasia or Endometrial Cancer with Simplified Ultrasound-Based Scoring Systems
    Stachowicz, Norbert
    Smolen, Agata
    Ciebiera, Michal
    Lozinski, Tomasz
    Poziemski, Pawel
    Borowski, Dariusz
    Czekierdowski, Artur
    DIAGNOSTICS, 2021, 11 (03)
  • [6] Morphological features associated with POLE mutations: Implications for risk assessment in endometrial carcinoma
    Kinloch, M.
    Bakhsh, S.
    Soslow, R.
    Lee, C. -h.
    McAlpine, J.
    McConechy, M.
    Gilks, B.
    VIRCHOWS ARCHIV, 2015, 467 : S20 - S20
  • [7] Model Predicting the Risk of Endometrial Hyperplasia Developing into Endometrial Cancer
    Su, Jing
    She, Lina
    Fan, Yang
    Wang, Honghong
    Zhang, Qiaorui
    Zhang, Jiao
    Ma, Hongyun
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 6159 - 6171
  • [8] Risk of occult atypical hyperplasia or cancer in women with nonatypical endometrial hyperplasia
    Lee, Nara
    Lee, Kwang-Beom
    Kim, Kidong
    Hong, Jin Hwa
    Yim, Ga Won
    Seong, Seok Ju
    Lee, Banghyun
    Lee, Jong-Min
    Cho, Jaehyun
    Lim, Soyi
    Ouh, Yung-Taek
    Kim, Yong Beom
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2020, 46 (12) : 2505 - 2510
  • [9] Assessing the risk of concurrent endometrial cancer among women with endometrial hyperplasia
    Lee, J.
    Maldonado, V.
    Eng, K.
    Lagiou, P.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (03) : S826 - S827
  • [10] Endometrial hyperplasia and endometrial cancer
    Burke, TW
    TortoleroLuna, G
    Malpica, A
    Baker, VV
    Whittaker, L
    Johnson, E
    Mitchell, MF
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1996, 23 (02) : 411 - +